Press release
2020 Neurodegenerative Drugs Market: Covering Prime Factors and Leading Key Players (GSK, Novartis, Pfizer, Merck Serono, TEVA, UCB, Sanofi) | Competitive Outlook Till 2025
Neurodegenerative Drugs Market
Overview of Global Neurodegenerative Drugs Market:
This report studies the Global Neurodegenerative Drugs Market over the forecast period of 2020 to 2025. The Global Neurodegenerative Drugs Market is expected to grow at an impressive Compound Annual Growth Rate (CAGR) from 2020 to 2025.
According to the market research report, the Neurodegenerative disease refers to the progressive damage or wear and tear of the nerve cells. Neurodegenerative disease causes loss of abilities like decision making and eventually memory loss. Neurodegenerative is a broader term which comprises of different disease namely Parkinson's disease, Huntington disease, Amyotrophic Lateral Sclerosis and Alzheimer's disease.
Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/247260 .
Some of the most significant key factors driving the growth of the Global Neurodegenerative Drugs Market are rapid growth in prevalence of neurological disorders, growing public awareness and strong product pipeline for neurodegenerative disease treatment.
The Global Neurodegenerative Drugs Market is segmented on the basis of Type, Application and Region. Based on the Type, the Global Neurodegenerative Drugs Market is sub-segmented into NMDA, SSRIs, Dopamine Inhibitors and others. On the basis of Application, the Global Neurodegenerative Drugs Market is classified into Parkinson's Disease, Huntington Disease, Amyotrophic Lateral Sclerosis, Alzheimer's Disease and others.
In terms of the geographic analysis, The Neurodegenerative Drugs Market in North America is expected to grow at the highest CAGR during the forecast period. Moreover, the presence of major players in the Neurodegenerative Drugs Market ecosystem results in the increasing adoption of these systems in North America.
Global Neurodegenerative Drugs Market Objectives:
1 To provide detailed information regarding key factors (drivers, restraints, opportunities, and industry-specific challenges) influencing the growth of the Neurodegenerative Drugs Market
2 To analyze and forecast the size of the Neurodegenerative Drugs Market, in terms of value and volume
3 To analyze opportunities in the Neurodegenerative Drugs Market for stakeholders and provide a competitive landscape of the market
4 To define, segment, and estimate the Neurodegenerative Drugs Market based on deposit type and end-use industry
5 To strategically profile key players and comprehensively analyze their market shares and core competencies
6 To strategically analyze micromarkets with respect to individual growth trends, prospects, and contribution to the total market
7 To forecast the size of market segments, in terms of value, with respect to main regions, namely, Asia Pacific, North America, Europe, the Middle East & Africa, and South America
8 To track and analyze competitive developments, such as new product developments, acquisitions, expansions, partnerships, and collaborations in the Neurodegenerative Drugs Market
Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on "Global Neurodegenerative Drugs Market Report 2020" @ https://www.businessindustryreports.com/buy-now/247260/single .
Top Leading Key Manufacturers are: Novartis, Pfizer, Merck Serono, Biogen Idec, TEVA, UCB, Boehringer Ingelheim, Sanofi, GlaxoSmithKline and others. New product launches and continuous technological innovations are the key strategies adopted by the major players.
Global Industry News:
GlaxoSmithKline (GSK) (February 27, 2020) - GSK filing accepted by European Medicines Agency for Trelegy Ellipta use in adult patients with asthma - GlaxoSmithKline plc (GSK) and Innoviva, Inc. (INVA) today announced the acceptance of a regulatory submission seeking an additional indication for the use of once-daily, single-inhaler triple therapy, Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol or FF/UMEC/VI) for the treatment of asthma in adults by the European Medicines Agency (EMA).
The submission is supported by the pivotal Phase III clinical study (CAPTAIN), conducted in 2,436 adult asthma patients across 15 countries whose disease remained inadequately controlled despite treatment with a combination of an inhaled corticosteroid and a long-acting ?2-agonist (ICS/LABA). The study met its primary endpoint, demonstrating a statistically significant improvement in lung function compared with the ICS/LABA, Relvar/Breo Ellipta.
There is currently no single inhaled triple therapy available for the treatment of asthma in Europe. Asthma, a chronic lung disease that inflames and narrows the airways, affects 358 million people worldwide. Even when adherent to ICS/LABA treatment, at least 30% of asthma patients continue to experience symptoms, indicating that they require further treatment.
Region segment: This report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Neurodegenerative Drugs in these regions, from 2013 to 2025 (forecast), covering: North America, Europe, Asia Pacific, Middle East & Africa and South America
Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/247260 .
Major Points in Table of Contents:
Global Neurodegenerative Drugs Market Report 2020
1 Neurodegenerative Drugs Product Definition
2 Global Neurodegenerative Drugs Market Manufacturer Share and Market Overview
3 Manufacturer Neurodegenerative Drugs Business Introduction
4 Global Neurodegenerative Drugs Market Segmentation (Region Level)
5 Global Neurodegenerative Drugs Market Segmentation (Product Type Level)
6 Global Neurodegenerative Drugs Market Segmentation (Industry Level)
7 Global Neurodegenerative Drugs Market Segmentation (Channel Level)
8 Neurodegenerative Drugs Market Forecast 2020-2025
9 Neurodegenerative Drugs Segmentation Product Type
10 Neurodegenerative Drugs Segmentation Industry
11 Neurodegenerative Drugs Cost of Production Analysis
12 Conclusion
................... Request free sample to get a complete Table of Content
About us
BusinessindustryReports.com is digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined - we want to help our clients envisage their business environment so that they are able to make informed, strategic and therefore successful decisions for themselves.
Media Contact
Business Industry Reports
Pune - India
sales@businessindustryreports.com
+19376349940
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release 2020 Neurodegenerative Drugs Market: Covering Prime Factors and Leading Key Players (GSK, Novartis, Pfizer, Merck Serono, TEVA, UCB, Sanofi) | Competitive Outlook Till 2025 here
News-ID: 1956349 • Views: …
More Releases from Business Industry Reports
Tetracaine Market Exhibits a Lucrative Growth Potential during 2021-2025 | Endo …
BusinessIndustryReports has recently broadcasted a new study to its broad research portfolio, which is titled as “Global Tetracaine Market” Research Report 2021 provides an in-depth analysis of the Tetracaine with the forecast of market size and growth. The analysis includes addressable market, market by volume, market share by business type and by segment (external and in-house). The research study examines the Tetracaine on the basis of a number of criteria,…
Cyber Warfare Market Evenly Poised To Reach A Market Value of US$ By Share, Size …
Overview of Global Cyber Warfare Market:
This report provides in-depth study of “Global Cyber Warfare Market 2021” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Cyber Warfare Market report also provides an in-depth survey of key players in the market organization.
According to the market research study, the Cyber Warfare is virtual conflict between state, organization, or country by the use of computer technology to disrupt activities…
Covid-19 Impact on Cranio Maxillofacial Implant Market 2021-2025: Business Growt …
Overview of Global Cranio Maxillofacial Implant Market:
This report provides in-depth study of “Global Cranio Maxillofacial Implant Market 2021” using SWOT analysis i.e. Strength, Weakness, Opportunities, and Threat to the organization. The Cranio Maxillofacial Implant Market report also provides an in-depth survey of key players in the market organization.
According to the market research study, Craniomaxillofacial Implants are medical implants used in surgeries of maxillofacial region such as, head, face, neck, oral,…
Beginning of the bloom: The Rise of the Biohacking Market 2021-2025 | Global Key …
Global Biohacking Market Synopsis:
The report covers a forecast and an analysis of the Biohacking Market on a global and regional level. The study provides historical data for 2015, 2016, 2017 and 2018 along with a forecast from 2020 to 2025 based on revenue (USD Million) and volume (Kilotons). The study includes drivers and restraints of the Biohacking Market along with the impact they have on the demand over the forecast…
More Releases for Neurodegenerative
Growing Prevalence Of Neurodegenerative Disorders Fuels Neurodegenerative Disord …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Neurodegenerative Disorder Therapeutics Market Size Growth Forecast: What to Expect by 2025?
In recent times, the market size for therapeutics for neurodegenerative disorders has seen robust growth. The growth is expected to rise from $18.53 billion in 2024 to $20.04 billion in 2025, maintaining a compound annual growth rate…
Growing Prevalence Of Neurodegenerative Disorders Fuels Neurodegenerative Disord …
"The Neurodegenerative Disorder Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Neurodegenerative Disorder Therapeutics Market Size and Its Estimated Growth Rate?
The neurodegenerative disorder therapeutics market has shown strong growth, expected to increase from $18.53 billion in 2024 to $20.04 billion…
Growing Prevalence Of Neurodegenerative Disorders Fuels Neurodegenerative Disord …
How Is the Neurodegenerative Disorder Therapeutics Market Projected to Grow, and What Is Its Market Size?
Seen significant expansion in recent years, the market size for neurodegenerative disorder therapeutics is predicted to climb from $18.53 billion in 2024 to $20.04 billion in 2025, maintaining a compound annual growth rate (CAGR) of 8.1%. The prior growth phase can be credited to factors such as an aging society, an upsurge in neurodegenerative disorder…
Growing Prevalence Of Neurodegenerative Disorders Fuels Neurodegenerative Disord …
How Is the Neurodegenerative Disorder Therapeutics Market Projected to Grow, and What Is Its Market Size?
Seen significant expansion in recent years, the market size for neurodegenerative disorder therapeutics is predicted to climb from $18.53 billion in 2024 to $20.04 billion in 2025, maintaining a compound annual growth rate (CAGR) of 8.1%. The prior growth phase can be credited to factors such as an aging society, an upsurge in neurodegenerative disorder…
Growing Prevalence Of Neurodegenerative Disorders Fuels Neurodegenerative Disord …
How Is the Neurodegenerative Disorder Therapeutics Market Projected to Grow, and What Is Its Market Size?
Seen significant expansion in recent years, the market size for neurodegenerative disorder therapeutics is predicted to climb from $18.53 billion in 2024 to $20.04 billion in 2025, maintaining a compound annual growth rate (CAGR) of 8.1%. The prior growth phase can be credited to factors such as an aging society, an upsurge in neurodegenerative disorder…
Novel Antibodies in Neurodegenerative Disease Treatment
Neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, represent some of the most challenging medical conditions due to their progressive nature and lack of effective treatments. Novel antibodies are emerging as promising therapeutic agents, offering targeted and innovative approaches to slow disease progression and improve patient outcomes. This article explores the role of novel antibodies in the treatment of neurodegenerative diseases, highlighting their mechanisms of action and therapeutic potential.
Download…
